These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
208 related items for PubMed ID: 2192902
1. Complement-dependent antibody-mediated cytotoxicity in the spontaneously diabetic BB/OK rat: association with beta cell volume density. Hehmke B, Lucke S, Schröder D, Klöting I, Kohnert KD. Eur J Immunol; 1990 May; 20(5):1091-6. PubMed ID: 2192902 [Abstract] [Full Text] [Related]
2. Early appearance of complement-dependent antibody mediated cytotoxicity (C'AMC) to islet cells in serum of diabetes-prone BB/OK rats. Hehmke B, Schröder D, Klöting I. Diabetes Res; 1990 Apr; 13(4):183-6. PubMed ID: 2134210 [Abstract] [Full Text] [Related]
3. Complement-dependent antibody-mediated cytotoxicity (C'AMC) to pancreatic islet cells in the spontaneously diabetic BB/OK rat: interference from cell-bound and soluble inhibitors. Hehmke B, Schröder D, Klöting I, Kohnert KD. J Clin Lab Immunol; 1991 Jun; 35(2):71-81. PubMed ID: 1668761 [Abstract] [Full Text] [Related]
4. Beta cell destruction of pancreatic islets transplanted into diabetic BB/OK rats may be reflected by increased antibody-mediated anti-islet cytotoxicity. Schröder D, Wanka H, Hehmke B, Klöting I, Köhler E, Knospe S, Schmidt S. Diabetes Res; 1990 Sep; 15(1):27-32. PubMed ID: 2132197 [Abstract] [Full Text] [Related]
6. Detection and time course of humoral-mediated cytotoxicity to different cell types in diabetes-prone BB/OK rats. Schröder D, Hehmke B, Klöting I, Schmidt S. Diabetes Res; 1991 Jun; 17(2):81-91. PubMed ID: 1817815 [Abstract] [Full Text] [Related]
7. Cytotoxic islet cell autoantibodies in newly diagnosed insulin-dependent diabetes mellitus: lack of correlation to age, residual beta cell function, HLA antigens and Coxsackie B virus antibodies. Hehmke B, Michaelis D, Hildmann W, Richter KV, Kohnert KD. Diabetes Res; 1987 Feb; 4(2):73-7. PubMed ID: 3034475 [Abstract] [Full Text] [Related]
8. Effect of syngeneic islet antigen administration on complement-dependent antibody-mediated cytotoxicity to islet cells and diabetes onset in diabetes-prone BB/OK rats. Schröder D, Schmidt S, Klöting I, Hehmke B. Autoimmunity; 1993 Feb; 14(4):283-9. PubMed ID: 8347771 [Abstract] [Full Text] [Related]
9. Prospective investigations of long-term normoglycaemic BB/OK-rats: serial determination of glucose tolerance, insulitis, B-cell volume density and pancreatic insulin content. Hahn HJ, Lucke S, Klöting I, Besch W. Exp Clin Endocrinol; 1991 Feb; 98(3):185-92. PubMed ID: 1778238 [Abstract] [Full Text] [Related]
10. Cell-mediated immune reactions against islets of Langerhans in diabetes-prone BB rats. Knospe S, Köhler E, Klöting I. Exp Clin Endocrinol; 1987 Aug; 89(3):290-6. PubMed ID: 3311775 [Abstract] [Full Text] [Related]
11. Cytotoxic activity of sera from diabetic BB rats against BB rat islet--a functional study. Ziegler B, Klöting I, Besch W, Ziegler M, Hahn HJ. Diabetes Res; 1987 Feb; 4(2):67-72. PubMed ID: 3555954 [Abstract] [Full Text] [Related]
12. Humoral-mediated cytotoxicity to rat pancreatic exocrine cells in serum of diabetes-prone BB/OK rats--predictive value for diabetes onset. Schröder D, Hehmke B, Klöting I, Schmidt S. Diabetes Res; 1993 Feb; 23(3):105-13. PubMed ID: 7712684 [Abstract] [Full Text] [Related]
13. Occurrence of islet cell reactive autoantibodies in diabetes-prone BB/OK rats is not associated with the onset of diabetes: a cross-sectional study of BB rats and their diabetes-resistant congenic strains. Schlosser M, Ziegler B, Augstein P, Klöting I, Ziegler M. Diabetes Res; 1994 Feb; 26(2):67-77. PubMed ID: 7554727 [Abstract] [Full Text] [Related]
14. The effects of sera obtained from children with insulin-dependent diabetes mellitus on cultivated islet cells: cytotoxicity and insulin release. Sadovnikova NV, Pankov YA, Fedotov VP, Czernushkina AV, Zhukovsky MA, Shcherbacheva LN. Exp Clin Endocrinol; 1989 May; 93(2-3):166-72. PubMed ID: 2673810 [Abstract] [Full Text] [Related]
15. Effects of transforming growth factor beta (TGF-beta) on the lymphocyte- and cytokine-mediated destruction of islet cells in the BB/Wor rat. Koevary SB. Lymphokine Cytokine Res; 1991 Oct; 10(5):337-42. PubMed ID: 1768735 [Abstract] [Full Text] [Related]
16. Effect of serum from diabetes-prone BB/OK rats on neonatal rat pancreatic islets and islet cell suspensions. Schröder D, Hehmke B, Klöting I, Besch W. Exp Clin Endocrinol; 1989 May; 93(2-3):187-92. PubMed ID: 2673813 [Abstract] [Full Text] [Related]
17. Is there an autoimmune process in bone? Gene expression studies in diabetic and nondiabetic BB rats as well as BB rat-related and -unrelated rat strains. Klöting N, Follak N, Klöting I. Physiol Genomics; 2005 Dec 14; 24(1):59-64. PubMed ID: 16189279 [Abstract] [Full Text] [Related]
18. Effects of incubation of islet cells with transforming growth factor beta (TGF-beta) on their susceptibility to diabetic lymphocyte mediated destruction in the rat, in vitro. Koevary SB. Diabetes Res; 1991 Nov 14; 18(3):123-7. PubMed ID: 1841822 [Abstract] [Full Text] [Related]
19. Islet cell antibodies in insulin-dependent (type 1) diabetic children treated with plasmapheresis. Marner B, Lernmark A, Ludvigsson J, MacKay P, Matsuba I, Nerup J, Rabinovitch A. Diabetes Res; 1985 Sep 14; 2(5):231-6. PubMed ID: 3905187 [Abstract] [Full Text] [Related]